Search results
Found 17940 matches for
The University of Oxford and Sound Pharmaceuticals completed this new Phase 2a study testing SPI-1005, an investigational drug that contains ebselen, as a new treatment for bipolar disorder.
Athena Swan renewal application form March 2024
Athena Swan renewal application form
Athena Swan renewal application form_v1-3_DoPsych_July2024_ AP v8 redacted clean.docx (2 MB)
Future Action Plan - Psychiatry July 2024
Athena Swan Future Action Plan July 2024
Psychiatry Annual Report 2023
Psychiatry annual report 2-23 - read a fully accessible version of the text below